Yvan de Launoit
Overview
Explore the profile of Yvan de Launoit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
2931
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodzinski E, Martin N, Rouget R, Pioger A, Dehennaut V, Molendi-Coste O, et al.
Med Sci (Paris)
. 2024 Mar;
40(3):275-282.
PMID: 38520103
Cells can be reprogrammed into senescence to adapt to a variety of stresses, most often affecting the genome integrity. Senescent cells accumulate with age or upon various insults in almost...
2.
Turpin A, Delliaux C, Parent P, Chevalier H, Escudero-Iriarte C, Bonardi F, et al.
Br J Cancer
. 2023 Oct;
129(12):1903-1914.
PMID: 37875732
Background: Neuroendocrine prostate cancer (NEPC) is an aggressive form of prostate cancer, arising from resistance to androgen-deprivation therapies. However, the molecular mechanisms associated with NEPC development and invasiveness are still...
3.
Goy E, Martin N, Drullion C, Saas L, Molendi-Coste O, Pineau L, et al.
Bio Protoc
. 2023 Apr;
13(7):e4612.
PMID: 37056241
Cellular senescence is a reprogrammed cell state triggered as an adaptative response to a variety of stresses, most often those affecting the genome integrity. Senescent cells accumulate in most tissues...
4.
Duplaquet L, Figeac M, Lepretre F, Frandemiche C, Villenet C, Sebda S, et al.
Mol Cancer Ther
. 2019 Mar;
18(6):1137-1148.
PMID: 30926633
Besides the detection of somatic receptor tyrosine kinases (RTK) mutations in tumor samples, the current challenge is to interpret their biological relevance to give patients effective targeted treatment. By high-throughput...
5.
Benkhelifa S, Rafa H, Belhadef S, Ait-Kaci H, Medjeber O, Belkhelfa M, et al.
Inflammopharmacology
. 2019 Jan;
27(4):685-700.
PMID: 30680650
Colorectal cancer (CRC) remains the most cancer type related to chronic inflammation; however, the mechanisms that link inflammation to CRC development and progression are still poorly understood. Our study aimed...
6.
Delliaux C, Tian T, Bouchet M, Fradet A, Vanpouille N, Flourens A, et al.
Cancer Lett
. 2018 Sep;
438:32-43.
PMID: 30201302
Prostate cancers have a strong propensity to metastasize to bone and promote osteoblastic lesions. TMPRSS2:ERG is the most frequent gene rearrangement identified in prostate cancer, but whether it is involved...
7.
Dumortier M, Ladam F, Damour I, Vacher S, Bieche I, Marchand N, et al.
Breast Cancer Res
. 2018 Jul;
20(1):73.
PMID: 29996935
Background: The ETS transcription factor ETV4 is involved in the main steps of organogenesis and is also a significant mediator of tumorigenesis and metastasis, such as in breast cancer. Indeed,...
8.
Rafa H, Benkhelifa S, AitYounes S, Saoula H, Belhadef S, Belkhelfa M, et al.
Mediators Inflamm
. 2017 Apr;
2017:7353252.
PMID: 28408791
Colitis associated cancer (CAC) is the colorectal cancer (CRC) subtype that is associated with bowel disease such as ulcerative colitis (UC). The data on role of NF-B signaling in development...
9.
Deplus R, Delliaux C, Marchand N, Flourens A, Vanpouille N, Leroy X, et al.
Oncotarget
. 2017 Jan;
8(7):11827-11840.
PMID: 28055969
Bone metastasis is the major deleterious event in prostate cancer (PCa). TMPRSS2-ERG fusion is one of the most common chromosomic rearrangements in PCa. However, its implication in bone metastasis development...
10.
Ouaguia L, Morales O, Mrizak D, Ghazal K, Boleslawski E, Auriault C, et al.
ISRN Hepatol
. 2016 Jun;
2013:928485.
PMID: 27335834
Hepatitis C virus (HCV) is an important causative agent of liver disease, but factors that determine the resolution or progression of infection are poorly understood. In this study, we suggested...